News
Telix & GMS Enters Commercial Distribution Agreement for Illuccix® in Australia
Melbourne (Australia) – 16 February 2022. Telix announces a commercial distribution agreement with Global Medical Solutions Australia (GMSA), for Illuccix® in the Australian market Telix is pleased to announce that it has entered into a commercial distribution...
GMS New Zealand To Exit NZMI Auckland Scanning Services
1 February 2022, Auckland, NZ, -- Global Medical Solutions (NZ) Ltd. (GMS) and Integral Diagnostics New Zealand (IDX), (a subsidiary of Integral Diagnostics Ltd, listed on Australia Stock Exchange (ASX:IDX)), have completed a transaction whereby GMS will divest...
GMS Australia Opens Its 6th Radiopharmacy – GMS Canberra
GMS Australia has just extended it's national radiopharmacy network with GMS Canberra opening it's doors this week! We'd like to introduce everyone to our amazing pharmacists who are excited to support the local nuclear medicine community by providing centralised...
GMS and HR Pharma Sign Distribution Agreement for EcoVue® in Asia-Pacific
HR Pharmaceuticals, Inc. (HR) and Global Medical Solutions, Ltd. (GMS) have entered into a distribution agreement to distribute HR’s EcoVue® Ultrasound Gel in GMS’s Asia-Pacific territories. GMS will register, distribute and market EcoVue® Ultrasound Gel in Australia,...
BWXT and GMS Form Joint Venture in Nuclear Medicine Manufacturing and Distribution in the Asia-Pacific Region
BWXT and GMS Form Joint Venture in Nuclear Medicine Manufacturing and Distribution in the Asia-Pacific Region
GMS Thailand Opens Its 3rd Radiopharmacy – GMS Korat
GMS Thailand has opened its 3rd radiopharmacy (GMS Korat), located at the Maharat Nakhon Ratchasima Hospital. A big thank you to the team at the Maharat Nakhon Ratchasima Hospital for the opportunity and a congratulations to the team at GMS Thailand for the planning...
NMP and GMS Announce Strategic Partnership in Nuclear Medicine
June 15, 2020Nihon Medi-Physics Co., Ltd.Global Medical Solutions, Ltd. Nihon Medi-Physics and Global Medical Solutions AnnounceStrategic Partnership in Nuclear Medicine Markets in Asia and Oceania Tokyo, Japan and Sherman Oaks, CA, USA– June 15, 2020. Nihon...
GMS TRODAT-1 is now available in a 30-vial kit
TRODAT-1 is now available in a 30-vial kit. The addition of this new package will aid our customers in their daily work of compounding and dispensing 99mTc-TRODAT-1 by being more space-efficient and user friendly. For more information about availability, please...
GMS Taiwan’s Taichung site receives approvals for GMP and FDG
GMS Taiwan has received both GMP certification of GMS Laboratory facility in Wufung, Taichung and TFDA marketing approval of FDG for the site. Our newest cyclotron will bring much needed capacity for FDG as well as new tracers for the Taiwan market. Thank you to the...
GMS’s TRODAT-1 Receives a R&D Silver Medal
GMS TRODAT-1 Kit is honored to receive the Silver Medal during the 2019 Taiwan Pharmaceutical Technology Research and Development Awards - Sponsored by the Taiwan FDA & Ministry of Economic Affairs. Pictured: (top) CEO & Chairman Haig Bagerdjian receiving the...
Recent Comments